Cawachi Limited

Tokyo Stock Exchange 2664.T

Cawachi Limited EBITDA Margin for the year ending March 31, 2024: 4.02%

Cawachi Limited EBITDA Margin is 4.02% for the year ending March 31, 2024, a 3.92% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Cawachi Limited EBITDA Margin for the year ending March 31, 2023 was 3.87%, a -10.43% change year over year.
Cawachi Limited EBITDA Margin for the year ending March 31, 2022 was 4.32%, a -17.88% change year over year.
Cawachi Limited EBITDA Margin for the year ending March 31, 2021 was 5.26%, a 39.64% change year over year.
Cawachi Limited EBITDA Margin for the year ending March 31, 2020 was 3.77%, a 12.25% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 2664.T

Cawachi Limited

CEO	Mr. Shinji Kawachi
IPO Date	Dec. 4, 2002
Location	Japan
Headquarters	1293 Soshima
Employees	2,722
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Cosmetics Eyewear Pharmaceuticals

Description

Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance business. The company operates 355 drugstores. Cawachi Limited was founded in 1967 and is headquartered in Oyama, Japan.

Key trends

Past 5 years